Ashina M, Tepper SJ, Reuter U, Blumenfeld AM, et al. Once-daily oral atogepant for the long-term preventive treatment of migraine: Findings from a multicenter, randomized, open-label, phase 3 trial. Headache 2023 Jan 18. doi: 10.1111/head.14439.
PMID: 36651532